Carcidiag Biotechnologies is a french startup that offers cancer glycosylation expertize. They have developed a diagnostic, fast, sensitive, specific and innovative tool for the detection of precancerous cells. They are based in Guéret, France.
Biotechnology, Life Science, medicine
Between €1 million-€ 2.5 million
💡 You’re a corporate or investor and looking for startups that are innovating in the same market as Carcidiag Biotechnologies? We’re happy to assist you with our Startup Sourcing service.